- Home
- JZXN vs RLYB Comparison
JZXN vs RLYB Comparison
Compare JZXN & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- RLYB
- Stock Information
- Founded
- JZXN 2019
- RLYB 2018
- Country
- JZXN China
- RLYB United States
- Employees
- JZXN N/A
- RLYB N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- RLYB Health Care
- Exchange
- JZXN Nasdaq
- RLYB Nasdaq
- Market Cap
- JZXN 23.5M
- RLYB 24.1M
- IPO Year
- JZXN 2021
- RLYB 2021
- Fundamental
- Price
- JZXN $0.37
- RLYB $0.56
- Analyst Decision
- JZXN
- RLYB Hold
- Analyst Count
- JZXN 0
- RLYB 2
- Target Price
- JZXN N/A
- RLYB N/A
- AVG Volume (30 Days)
- JZXN 7.8M
- RLYB 315.1K
- Earning Date
- JZXN 03-05-2026
- RLYB 11-06-2025
- Dividend Yield
- JZXN N/A
- RLYB N/A
- EPS Growth
- JZXN N/A
- RLYB N/A
- EPS
- JZXN N/A
- RLYB N/A
- Revenue
- JZXN $97,465.00
- RLYB $761,000.00
- Revenue This Year
- JZXN N/A
- RLYB N/A
- Revenue Next Year
- JZXN N/A
- RLYB N/A
- P/E Ratio
- JZXN N/A
- RLYB N/A
- Revenue Growth
- JZXN N/A
- RLYB 154.51
- 52 Week Low
- JZXN $0.36
- RLYB $0.22
- 52 Week High
- JZXN $7.82
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- JZXN 33.50
- RLYB 50.25
- Support Level
- JZXN $0.40
- RLYB $0.48
- Resistance Level
- JZXN $0.48
- RLYB $0.60
- Average True Range (ATR)
- JZXN 0.24
- RLYB 0.04
- MACD
- JZXN -0.08
- RLYB -0.00
- Stochastic Oscillator
- JZXN 0.70
- RLYB 47.74
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.